This is a prospective single arm study enrolling patients who are scheduled for creation of a new Brachiocephalic AV fistula. Up to 50 patients will be enrolled. All patients will be implanted with the VasQ device, a subcutaneous arteriovenous conduit support for vascular access. The follow up period in this study will be for a duration of 12 months, with follow up visits scheduled at 1, 3, 6, 9, and 12 months.